Nikolay Dygalo

Prof. Nikolay Dygalo

Institute of Cytology and Genetics SB RAS

Research Focus & Metrics

Academic Career Length

42Years (1985-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 June 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MSMikhail Stepanichev
Mikhail Stepanichev
NDNikolay Dygalo
Nikolay Dygalo
GGGrigory Grigoryan
Grigory Grigoryan
GSGalina T. Shishkina
Galina T. Shishkina
Natalia V. GulyaevaNatalia V. Gulyaeva
Natalia V. Gulyaeva
Rodent models are an indispensable tool for studying etiology and progress of depression. Since interrelated systems of neurotrophic factors and cytokines comprise major regulatory mechanisms controlling normal brain plasticity, impairments of these systems form the basis for development of cerebral pathologies, including mental diseases. The present review focuses on the numerous experimental rodent models of depression induced by different stress factors (exteroceptive and interoceptive) during early life (including prenatal period) or adulthood, giving emphasis to the data on the changes of neurotrophic factors and neuroinflammatory indices in the brain. These parameters are closely related to behavioral depression-like symptoms and impairments of neuronal plasticity and are both gender- and genotype-dependent. Stress-related changes in expression of neurotrophins and cytokines in rodent brain are region-specific. Some contradictory data reported by different groups may be a consequence of differences of stress paradigms or their realization in different laboratories. Like all experimental models, stress-induced depression-like conditions are experimental simplification of clinical depression states; however, they are suitable for understanding the involvement of neurotrophic factors and cytokines in the pathogenesis of the disease—a goal unachievable in the clinical reality. These major regulatory systems may be important targets for therapeutic measures as well as for development of drugs for treatment of depression states.

1 May 1989 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
ENE.V. Naumenko
E.V. Naumenko
NPN.K. Popova
N.K. Popova
ENE.M. Nikulina
E.M. Nikulina
NDNikolay Dygalo
Nikolay Dygalo
GSG.T. Shishkina
G.T. Shishkina
AMA.L. Markel
A.L. Markel


1 December 2010 in Behavioural Brain Research
Verified
Journal Article
Closed access
GSGalina T. Shishkina
Galina T. Shishkina
TKTatyana S. Kalinina
Tatyana S. Kalinina
IBInna V. Berezova
Inna V. Berezova
VBVeta V. Bulygina
Veta V. Bulygina
NDNikolay Dygalo
Nikolay Dygalo


1 July 2016 in Neurobiology of Disease
Verified
Journal Article
Closed access
DLDmitriy Lanshakov
Dmitriy Lanshakov
ESEkaterina V. Sukhareva
Ekaterina V. Sukhareva
TKTatjana S. Kalinina
Tatjana S. Kalinina
NDNikolay Dygalo
Nikolay Dygalo